GPT and fatty liver disease: The patient had a history of fatty liver with abnormal liver function, and during the early stages of treatment, chemotherapy induced elevations in AST (up to 189 U/L) and ALT (up to 114 U/L), placing her at high risk of 6-MP–related hepatotoxicity.